U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2448124481Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic HyperplasiaCompletedNo Results AvailableProstatic HyperplasiaDrug: ALNA®https://ClinicalTrials.gov/show/NCT02244268
2448224482FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNo Results AvailableProstatic HyperplasiaDrug: FLOMAX® capsules|Drug: Ascending doses of HYTRIN® capsuleshttps://ClinicalTrials.gov/show/NCT02244255
2448324483Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNo Results AvailableProstatic HyperplasiaDrug: Tamsulosin hydrochloridehttps://ClinicalTrials.gov/show/NCT02244242
2448424484Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) PatientsCompletedNo Results AvailableProstatic HyperplasiaDrug: Tamsulosin|Drug: Finasteride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02244229
2448524485Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract DiseaseCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Berotec® N 100 µg Metered-dose Inhalerhttps://ClinicalTrials.gov/show/NCT02244216
2448624486Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 60732|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02244203
2448724487Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Tipranavir|Drug: Tipranavir|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT02244190
2448824488Relationship of Essential Hypertension and Its Treatments on the Postoperative Pain Management: a Prospective, Observational, Cross-sectional StudyRecruitingNo Results AvailableHypertensionhttps://ClinicalTrials.gov/show/NCT02244177
2448924489Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.RecruitingNo Results AvailableType 2 Diabetes|Incretinomimetics|PancreasDrug: Incretinomimetics|Drug: DPP-4 inhibitorshttps://ClinicalTrials.gov/show/NCT02244164
2449024490Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte RetrievalRecruitingNo Results AvailableFemale Urogenital Diseases.Drug: Decapeptyl® diario|Drug: Decapeptyl® dailyhttps://ClinicalTrials.gov/show/NCT02244151
2449124491Improving Adolescent Health Outcomes Through Preventive Care TransformationRecruitingNo Results AvailableSexually Transmitted Diseases|Depression Diagnosis|Substance Use DisordersBehavioral: Adolescent CDSShttps://ClinicalTrials.gov/show/NCT02244138
2449224492A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 TrialRecruitingNo Results AvailableMultiple Myeloma|First RelapseDrug: PCD|Procedure: Autologous transplantation (ASCT)https://ClinicalTrials.gov/show/NCT02244125
2449324493A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced MalignanciesActive, not recruitingNo Results AvailableAdvanced Non-Central Nervous System (CNS) MalignanciesDrug: Oprozomib|Drug: Midazolamhttps://ClinicalTrials.gov/show/NCT02244112
2449424494Controlled Substance Treatment Agreements in an Internal Medicine Residents' ClinicCompletedNo Results AvailableAnxiety|Chronic Pain|Opioid Use, UnspecifiedOther: Controlled Substancehttps://ClinicalTrials.gov/show/NCT02244099
2449524495Analgesic Efficacy of Two Concentrations of Bupivacaine in Women in LaborCompletedNo Results AvailableObstetric PainDrug: bupivacainehttps://ClinicalTrials.gov/show/NCT02244086
2449624496Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.RecruitingNo Results AvailableCritical IllnessDrug: Human insulin - Insulin administration to control blood glucose level.https://ClinicalTrials.gov/show/NCT02244073
2449724497Eye Examinations as a Gold Standard to Evaluating Survey InstrumentsCompletedNo Results AvailableSelf Report|Questionnaire DesignOther: Priming effect from vignettehttps://ClinicalTrials.gov/show/NCT02244060
2449824498Cytokine Profile in Children With Celiac DiseaseCompletedNo Results AvailableCeliac DiseaseDrug: Bifidobacterium breve|Drug: Placebo (for Bifidobacterium breve)https://ClinicalTrials.gov/show/NCT02244047
2449924499Incidence and Risk Factors of Postoperative Hypothermia in Cardiac SurgeryRecruitingNo Results AvailablePostoperative Hypothermia in Patients With Cardiopulmonary Bypasshttps://ClinicalTrials.gov/show/NCT02244034
2450024500A Pilot Phase II Study With BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients Non Responding to IGEV Salvage TreatmentRecruitingNo Results AvailableRelapsed/Refractory Hodgkin's LymphomaDrug: BRENTUXIMAB VEDOTINhttps://ClinicalTrials.gov/show/NCT02244021
2450124501Accumulative Effects of Talus MobilizationCompletedNo Results AvailableAnkle Sprains|Ankle Fractures|Ankle Dislocations|Ankle Bruises|Achilles Tendon RuptureOther: joint mobilization|Other: manual contacthttps://ClinicalTrials.gov/show/NCT02244008
2450224502Physical Training in Sarcoidosis PatientsEnrolling by invitationNo Results AvailableSarcoidosisOther: Physical training|Behavioral: Physical traininghttps://ClinicalTrials.gov/show/NCT02243995
2450324503Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's DiseaseCompletedNo Results AvailableParkinson's Disease|Parkinson-Dementia SyndromeOther: [F18]-FDDNPhttps://ClinicalTrials.gov/show/NCT02243982
2450424504Alpha-linolenic Acid and Blood PressureActive, not recruitingNo Results AvailableHypertension|Lipid Metabolism DisordersDietary Supplement: Flaxseed oil|Dietary Supplement: high oleic sunflower oil (HOSF)https://ClinicalTrials.gov/show/NCT02243969
2450524505Effects on Cognitive Functions and Mood of Food Products Rich in PolyphenolsCompletedNo Results AvailableCognitive Performance.|Mood.|Cardiometabolic Risk MarkersOther: Flavanol rich food producthttps://ClinicalTrials.gov/show/NCT02243956
2450624506Effect of Neuromuscular Reversal With Sugammadex on Postoperative Recovery ProfileRecruitingNo Results AvailablePostoperative Respiratory ConditionDrug: Sugammadex|Drug: Neostigminehttps://ClinicalTrials.gov/show/NCT02243943
2450724507Cap-assisted Sigmoidoscopy - Influence on Pain, Duration and Rate of SuccessCompletedNo Results AvailablePainDevice: Disposable distal attachmenthttps://ClinicalTrials.gov/show/NCT02243930
2450824508A Phase 1 Study Evaluating CB-5083 in Patients With Advanced Solid TumorsRecruitingNo Results AvailableAdvanced Solid TumorsDrug: CB-5083https://ClinicalTrials.gov/show/NCT02243917
2450924509Study for Promotion of Health in Recycling LeadNot yet recruitingNo Results AvailableOccupational Exposurehttps://ClinicalTrials.gov/show/NCT02243904
2451024510AF Ablation With or Without ROX Coupler StudyNot yet recruitingNo Results AvailableAtrial Fibrillation|HypertensionProcedure: Atrial fibrillation ablation|Procedure: ROX Coupler insertionhttps://ClinicalTrials.gov/show/NCT02243891

* Görseller ve İçerik tekif hakkına sahip olabilir